Morgan Stanley keeps AUD 3.30 target for Sigma Healthcare stock

Published on 10/17/2026 at 22:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The AGM is October 21, 2026. Sigma Healthcare stock last traded at AUD 2.85 on October 16, 2026, up 1.42 percent versus the ASX prior close.

Analyst target and AGM date

Morgan Stanley set an AUD 3.30 target for Sigma Healthcare on October 14, 2026.
Sigma Healthcare's annual general meeting is scheduled for October 21, 2026.
Sigma Healthcare stock was last at AUD 2.85 on October 16, 2026, up 1.42 percent versus the ASX prior close.
Sigma Healthcare traded at a P/E ratio of 46.27 with a market capitalization of AUD 32.8 billion.

Sigma, AU000000SIG5, Illustration mit AI erstellt.

On October 14, 2026, Morgan Stanley maintained its Buy rating on Sigma Healthcare and set an AUD 3.30 price target, according to The Globe and Mail. The target is 15.79 percent above Sigma Healthcare's latest ASX price in the same currency. Sigma Healthcare was last at AUD 2.85 on October 16, 2026 at 4:20 p.m. AEDT, up 1.42 percent versus the ASX prior close of October 15, 2026.

Annual meeting sets October 21

Sigma Healthcare's annual general meeting is scheduled for October 21, 2026. The agenda includes board re-elections and a vote on CEO pay, according to Simply Wall St. That date gives the stock a specific governance checkpoint after the latest analyst update.

Price sits below yearly high

The latest ASX price was 10.94 percent below Sigma Healthcare's AUD 3.20 52-week high and 15.38 percent above its AUD 2.47 low. The range and price are dated October 16, 2026. Trading volume reached 18,147,474 shares, compared with average volume of 17,414,765 shares.

Valuation and company scale

Sigma Healthcare carried a market capitalization of AUD 32.8 billion and a P/E ratio of 46.27 on October 16, 2026. The finance profile identifies the company as a healthcare business focused on medical distribution. Global Banking and Finance Review identifies Sigma Healthcare as SIG.AX on the ASX under ISIN AU000000SIG5.

Comparison with peers

Sigma Healthcare (ASX, AUD): plus 1.42 percent, P/E 46.27, market capitalization AUD 32.8 billion.

Ebos Group (ASX, AUD): plus 0.91 percent, P/E 15.50, market capitalization AUD 3.5 billion.

McKesson (NYSE, USD): plus 0.62 percent, P/E 26.89, market capitalization USD 117.2 billion.

What the next session carries

The October 21 annual general meeting is the next dated corporate event, while the AUD 3.30 Morgan Stanley target remains the clearest valuation marker in the recent market discussion.

The further course of trading is shown by the latest ASX price of AUD 2.85 on October 16, 2026 at 4:20 p.m. AEDT, with the stock 1.42 percent above the ASX prior close of October 15, 2026.